Supplementary Figures 1 Through 5 and Supplementary Tables 1 Through 3 from Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients is Determined by a Four-Parameter Tumor Immune Signature
crossref(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要